Xeris Biopharma director John Johnson sells $91,422 in shares

Key facts

• Xeris Biopharma director John Johnson sold shares.
• The value of the shares sold was $91,422.
• The sale involved 91,422 shares.
• The transaction was disclosed in a recent SEC filing.

Xeris Biopharma director John Johnson has sold 91,422 shares of the company's stock. The total value of this transaction amounts to $91,422. This insider trading activity was recently disclosed in a filing with the U.S. Securities and Exchange Commission (SEC).